IWC
KPTI icon

Integrated Wealth Concepts’s Karyopharm Therapeutics KPTI Stock Holding History

Integrated Wealth Concepts’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32K Buy
+134
New +$1.16K ﹤0.01% 5472

Other funds holding KPTI

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Integrated Wealth Concepts's KPTI Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Karyopharm Therapeutics (KPTI) in Q2 2026: 134 shares worth $1.32K. The stake represents ﹤0.01% of the portfolio and ranks #5472 among its holdings.

97 funds tracked by Wall St. Rank hold KPTI as of Q2 2026.

  • Integrated Wealth Concepts held 134 shares of Karyopharm Therapeutics worth $1.32K as of Q2 2026.
  • Karyopharm Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Karyopharm Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #5472 holding.
  • 97 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.